Literature DB >> 25677089

Resveratrol increases CD68⁺ Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice.

Kahoko Nishikawa1, Keiichi Iwaya2, Manabu Kinoshita3, Yoko Fujiwara4, Mai Akao4, Mariko Sonoda4, Suresh Thiruppathi5, Takayoshi Suzuki5, Sadayuki Hiroi6, Shuhji Seki3, Toshihisa Sakamoto7.   

Abstract

SCOPE: Resveratrol reportedly improves fatty liver. This study purposed to elucidate the effect of resveratrol on fatty liver in mice fed a high-fat (HF) diet, and to investigate the role of liver macrophages (Kupffer cells). METHODS AND
RESULTS: C57BL/6 mice were divided into three groups, receiving either a control diet, HF diet (50% fat), or HF supplemented with 0.2% resveratrol (HF + res) diet, for 8 weeks. Compared with the HF group, the HF + res group exhibited markedly attenuated fatty liver, and reduced lipid droplets (LDs) in hepatocytes. Proteomic analysis demonstrated that the most downregulated protein in the livers of the HF + res group was adipose differentiation-related protein (ADFP), which is a major constituent of LDs and reflects lipid accumulation in cells. The HF + res group exhibited greatly increased numbers of CD68(+) Kupffer cells with phagocytic activity. Immunohistochemistry showed that several CD68(+) Kupffer cells were colocalized with ADFP immunoreaction in the HF + res group. Additionally, the HF + res group demonstrated markedly decreased TNF-alpha production, which confirmed by both liver mononuclear cells stimulated by LPS in vitro and in situ hybridization analysis, compared with the HF group.
CONCLUSION: Resveratrol ameliorated fatty liver and increased CD68-positive Kupffer cells with downregulating ADFP expression.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Fatty liver; Kupffer cells; Lipid droplets; Lipid metabolism; Resveratrol

Mesh:

Substances:

Year:  2015        PMID: 25677089     DOI: 10.1002/mnfr.201400564

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  8 in total

1.  The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation.

Authors:  Xiaolu Wang; Yun Gao; Juan Song; Chao Tang; Man Wang; Linli Que; Li Liu; Guoqing Zhu; Qi Chen; Yong Yao; Yong Xu; Jiantao Li; Yuehua Li
Journal:  Br J Pharmacol       Date:  2017-04-26       Impact factor: 8.739

2.  Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice.

Authors:  Hiroyuki Nakashima; Masahiro Nakashima; Manabu Kinoshita; Masami Ikarashi; Hiromi Miyazaki; Hiromi Hanaka; Junko Imaki; Shuhji Seki
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

3.  Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis.

Authors:  Takaomi Kessoku; Kento Imajo; Yasushi Honda; Takayuki Kato; Yuji Ogawa; Wataru Tomeno; Shingo Kato; Hironori Mawatari; Koji Fujita; Masato Yoneda; Yoji Nagashima; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

4.  Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway.

Authors:  Yun-Xia Shao; Xing-Xin Xu; Kun Wang; Xiang-Ming Qi; Yong-Gui Wu
Journal:  Drug Des Devel Ther       Date:  2017-11-09       Impact factor: 4.162

5.  Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats.

Authors:  Iñaki Milton-Laskibar; Leixuri Aguirre; Alfredo Fernández-Quintela; Anabela P Rolo; João Soeiro Teodoro; Carlos M Palmeira; María P Portillo
Journal:  Nutrients       Date:  2017-07-11       Impact factor: 5.717

Review 6.  Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review.

Authors:  Xiao Meng; Jing Zhou; Cai-Ning Zhao; Ren-You Gan; Hua-Bin Li
Journal:  Foods       Date:  2020-03-14

Review 7.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives.

Authors:  Natascha Roehlen; Emilie Crouchet; Thomas F Baumert
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

Review 8.  Progress in the Application of Drugs for the Treatment of Multiple Sclerosis.

Authors:  Weipeng Wei; Denglei Ma; Lin Li; Lan Zhang
Journal:  Front Pharmacol       Date:  2021-07-13       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.